Dj. Socci et Gw. Arendash, CHRONIC NICOTINE TREATMENT PREVENTS NEURONAL LOSS IN NEOCORTEX RESULTING FROM NUCLEUS BASALIS LESIONS IN YOUNG-ADULT AND AGED RATS, Molecular and chemical neuropathology, 27(3), 1996, pp. 285-305
In both young adult and aged rats, we tested the ability of chronicall
y administered nicotine to rescue neocortical neurons from transneuron
al degeneration resulting 5 mo after ibotenic acid (IBO) lesioning of
the nucleus basalis magnocellularis (NBM). Young adult (2-3 mo-old) an
d aged (20-22-mo-old) rats were given unilateral infusions of IBO (5 m
u g/1 mu L) at two sites within the NBM. Following surgery, animals be
gan receiving either daily ip injections of nicotine (0.2 mg/kg) or sa
line vehicle. Treatment continued for 5 mo, at which time all animals
were sacrificed and their brains processed histologically. For each br
ain, computer-assisted image analysis was then used to analyze the unl
esioned (left) and lesioned (right) side of five nonconsecutive brain
sections from parietal cortex Layers II-IV and V. NBM lesioning in bot
h young adult and aged vehicle-treated rats resulted in a significant
16-21% neuronal loss ipsilateral to NBM lesioning in neocortical Layer
s II-IV. Aged NBM-lesioned rats also exhibited a significant 12% neuro
nal loss in neocortical Layer V ipsilaterally. By contrast, those NBM-
lesioned young adult and aged rats that received daily nicotine treatm
ent postsurgery did not show any ipsilateral neuronal loss in the same
parietal cortex areas, indicating that chronic nicotine treatment pre
vented the transneuronal degeneration of neocortical neurons resulting
5 mo afer NBM lesioning. Nicotine treatment alone did not have any ef
fect on neuronal density, neuronal size, or glial cell numbers in the
neocortex. The neuroprotective/neurotrophic action of nicotine in the
neocortex following NBM lesions may involve activation of pre- and/or
postsynaptic nicotinic receptors to maintain depolarizing influences o
r neurotrophin synthesis, or it may involve nicotine's ability to incr
ease glucose utilization and cerebral blood flow.